Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Oncology Institute (TOI) Receivables - Net: 2020-2025

Historic Receivables - Net for Oncology Institute (TOI) over the last 6 years, with Q3 2025 value amounting to $59.6 million.

  • Oncology Institute's Receivables - Net rose 942.53% to $59.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $59.6 million, marking a year-over-year increase of 942.53%. This contributed to the annual value of $48.3 million for FY2024, which is 1410.53% up from last year.
  • Per Oncology Institute's latest filing, its Receivables - Net stood at $59.6 million for Q3 2025, which was up 942.53% from $55.7 million recorded in Q2 2025.
  • Over the past 5 years, Oncology Institute's Receivables - Net peaked at $59.6 million during Q3 2025, and registered a low of $20.0 million during Q4 2021.
  • Over the past 5 years, Oncology Institute's median Receivables - Net value was $47.4 million (recorded in 2023), while the average stood at $44.5 million.
  • Per our database at Business Quant, Oncology Institute's Receivables - Net surged by 9901.03% in 2022 and then plummeted by 1606.54% in 2025.
  • Over the past 5 years, Oncology Institute's Receivables - Net (Quarter) stood at $20.0 million in 2021, then skyrocketed by 99.01% to $39.8 million in 2022, then increased by 6.39% to $42.4 million in 2023, then rose by 14.11% to $48.3 million in 2024, then increased by 23.39% to $59.6 million in 2025.
  • Its last three reported values are $59.6 million in Q3 2025, $55.7 million for Q2 2025, and $49.3 million during Q1 2025.